Alterity Therapeutics (ATHE) Other Non-Current Assets (2009 - 2016)
Alterity Therapeutics' (ATHE) quarterly Other Non-Current Assets came in at $32998.0 in Q4 2016, up 0.85% year-on-year from $32718.6 in Q1 2016, and little changed quarter-over-quarter from $32845.9 in Q2 2016.
Alterity Therapeutics (ATHE) Other Non-Current Assets (2009 - 2016) Analysis & Trends
Alterity Therapeutics' Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $32998.0 for Q4 2016.
- On a quarterly basis, Other Non-Current Assets rose 0.85% year-over-year to $32998.0 in Q4 2016; TTM through Dec 2016 was $32998.0, a 0.85% increase from a year earlier, with the FY2016 full-year figure at $32998.0, changed N/A from the prior year.
- Other Non-Current Assets steadied at $32998.0 in Q4 2016 per ATHE's latest filing, from $32845.9 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $43699.5 in Q2 2013 and bottomed at $32718.6 in Q4 2015.
- The 5-year median for Other Non-Current Assets is $37931.7 (2012), against an average of $37458.4.
- Across the five-year window, Other Non-Current Assets grew 14.29% in 2013 and decreased 13.84% in 2015, its largest moves.
- Year by year, Other Non-Current Assets stood at $39286.3 in 2012, then increased by 3.88% to $40810.8 in 2013, then slipped by 7.8% to $37627.8 in 2014, then decreased by 13.05% to $32718.6 in 2015, then climbed by 0.85% to $32998.0 in 2016.
- Per Business Quant, the three latest ATHE Other Non-Current Assets figures stand at $32998.0 (Q4 2016), $32845.9 (Q2 2016), and $32718.6 (Q4 2015).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 60,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 104.24 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 14.48 Mn |
| 10 | Alterity Therapeutics | 29.68 Bn | 29.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 32,997.97 |
| Jun 30, 2016 | 32,845.95 |
| Dec 31, 2015 | 32,718.55 |
| Jun 30, 2015 | 35,343.19 |
| Dec 31, 2014 | 37,627.80 |
| Jun 30, 2014 | 41,018.70 |
| Dec 31, 2013 | 40,810.81 |
| Jun 30, 2013 | 43,699.45 |
| Dec 31, 2012 | 39,286.30 |
| Jun 30, 2012 | 38,235.56 |
| Dec 31, 2011 | 38,255.11 |
| Jun 30, 2011 | 40,170.93 |
| Dec 31, 2010 | 35,164.00 |
| Jun 30, 2010 | 31,086.25 |
| Dec 31, 2009 | 35,164.00 |
| Jun 30, 2009 | 26,687.62 |